How profitable is Innospec Inc. (IOSP)?

In FY 2025 (10-K), IOSP converted $1.8B of revenue into a 27.7% gross margin, 7.3% operating margin, and $138.3M in free cash flow (7.8% FCF margin).

Stock Ratings / Materials / IOSP / financials

NGVT (66) ROG (48) KWR (46) WDFC (73) ⌘ Pro Terminal →

Innospec Inc. (IOSP) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$99.55 -0.34% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $99.30

Innospec Inc. (IOSP) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 69/100 (C+) historically posted market-perform odds over rolling 90-day windows (+2.0% avg 90D alpha vs SPY) →

ROARABLE C+ • HOLD / WATCH Cap $2.46B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on IOSP Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is IOSP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Innospec Inc. (NASDAQ: IOSP) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $99.55 (-0.34% 1D, market cap $2.46B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 13/20. Across 270 tracked Materials issuers, IOSP ranks #11 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does IOSP compare to NGVT and ROG in the Materials sector?

▼

Within the Materials sector (Major Chemicals), IOSP carries a Roarable C+ (69/100 RQD), trailing P/E of N/A, gross margin of 27.7%, and ROIC of 9.9%. By comparison, NGVT (Ingevity Corporation) holds a C+ grade (66/100 RQD, P/E N/A, ROIC 85.0%, cap $2.55B) and ROG (Rogers Corporation) posts a D grade (48/100 RQD, P/E N/A, ROIC -3.6%, cap $2.37B). Among the 5-stock peer group, WDFC leads on earnings multiple (32.3x) while NGVT leads on capital efficiency (85.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for IOSP?

▼

Per IOSP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001054905), Innospec Inc. generated $1.78B in revenue (-3.7% YoY), $0 in net income, and $138.3M in free cash flow against $1.83B in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $99.30 (-0.25%)🧬 Cannibal Buyback (-1.52% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 7.8% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 69/100 (C+) historically posted market-perform odds over rolling 90-day windows (+2.0% avg 90D alpha vs SPY • 57.3% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C+

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for IOSP)Realized 20D OHLCV Swing Band: ±3.9%

Deterministic 5-Pillar Attribution (69/100 Composite)

🔍 WHY IOSP SCORES 69/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+16/20 pts (23% of score)

20D Institutional Volume Accumulation (±3.9% realized swing band)

▲ #2 Bullish Driver: Cash Engine Quality+14/20 pts (20% of score)

SEC XBRL FY 2025 (10-K): 7.8% FCF Margin ($138.3M FCF) & 27.7% Gross Margin

▼ #1 Drag / Risk Factor: Macro Regime Fit12/20 pts (-8 pt drag)

Macro rate sensitivity & RSI-14 (57) create a -8 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$97.43+1.8% Next Q

Q2 (-2Q)

Grade C+$99.16+0.8% Next Q

Q3 (-1Q)

Grade B-$99.92-0.4% Next Q

Current

Grade C+$99.55+2% Hist 90D α

Trajectory: C (61) → C+ (69)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the IOSP Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 69/100 (C+) score, IOSP faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) — any gross margin slip below 25.2% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($96.29) or 200D SMA ($84.57) invalidates the momentum regime and cuts Target Base ($104.48) toward Bear Floor ($81.49).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $IOSP• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “IOSP Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 69%NO 31%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How IOSP Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$138.3M (7.8% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $1.95B

FY24

Rev $1.85B

FY25

Rev $1.78B

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$1.78B	27.7%	7.3%	$0	$138.3M	9.9%
FY 2024	$1.85B	29.4%	9.6%	$0	$184.5M	15.2%
FY 2023	$1.95B	27.7%	8.3%	$0	$207.3M	9.9%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring IOSP)

✓Walkthrough of IOSP's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

IOSP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +30.16%▲ ASCENDING CHANNEL

2026-11-03O $101.4H $101.4L $99.55C $99.55VOL 216.5K

RES: $105.1SUP: $87.59SMA50: $96.29SMA200: $84.57

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

IOSP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 IOSP Butterfly Map → + Track IOSP →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

14.9%/yr Implied 5Y Growth

vs. -3.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on IOSP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for IOSP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for IOSP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (IOSP)

Materials Rank #11 of 270 ⚔️ NGVT vs IOSP Full Matrix →

1. Head-to-Head Materials Peer Comparison (IOSP vs. NGVT, ROG, KWR, WDFC)

Industry: Major Chemicals (67 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, Innospec Inc. (IOSP) ranks #11 by composite RQD confidence (69/100, grade C+) and #103 by equity capitalization ($2.46B). Within this direct 5-issuer industry benchmark cohort, WDFC leads on earnings valuation at 32.3x trailing P/E, while NGVT leads on capital efficiency and profitability with 85.0% ROIC and 39.5% gross margin. WDFC currently holds the highest overall quantitative score in the immediate peer group at 73/100 (B) compared with IOSP at 69/100 (C+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
IOSP ACTIVE Innospec Inc.	C+	69/100	—	27.7%	9.9%	-0.34%	$2.46B	Benchmark Subject
NGVT Ingevity Corporation	C+	66/100	—	39.5%	85.0%	-0.82%	$2.55B	/ngvt-vs-iosp →
ROG Rogers Corporation	D	48/100	—	31.7%	-3.6%	-3.53%	$2.37B	/rog-vs-iosp →
KWR Quaker Houghton	D	46/100	—	36.0%	2.1%	-1.92%	$2.60B	/kwr-vs-iosp →
WDFC WD-40 Company	B	73/100	32.3x	55.1%	27.2%	+3.27%	$2.95B	/wdfc-vs-iosp →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001054905

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Innospec Inc. (IOSP) reported GAAP revenue of $1.78B (-3.7% vs. FY2024 revenue of $1.85B , and -8.8% cumulative change since FY2023) , GAAP net income of $0, operating cash flow of $138.3M, and free cash flow of $138.3M (-25.0% YoY). On the balance sheet, IOSP closed FY2025 with $1.83B in total assets against $0 in total debt (Altman Z-Score: 5.47, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.78B	$0	$138.3M	$138.3M	$1.83B	—
FY2024 (FY)	2024-12-31	$1.85B	$0	$184.5M	$184.5M	$1.73B	—
FY2023 (FY)	2023-12-31	$1.95B	$0	$207.3M	$207.3M	—	—

3. IOSP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is IOSP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does IOSP compare to NGVT and ROG in the Materials sector?

What are the biggest fundamental strengths and SEC risk factors for IOSP?

Where is IOSP trading relative to its 50-day, 200-day, and 52-week technical levels?

IOSP last traded at $99.55 (-0.34% on volume of 207,843 shares), positioning the stock +3.39% above its 50-day simple moving average ($96.29) and +17.71% above its 200-day simple moving average ($84.57). Across its 52-week range of $65.51 to $102.00, IOSP sits at the 93.3% percentile with a 14-day RSI of 57.0 (BULLISH MOMENTUM) and an implied next-earnings move of ±3.9% ($95.67 to $103.43).

Direct Sub-Reports: IOSP RQD Cockpit IOSP 12M Forecast IOSP Earnings & Move IOSP Dividends & DRIP IOSP Insiders & 13F IOSP Whale Options IOSP Profit Sankey IOSP News & Why

ROARABLE RATING BRIEF • RQD 69/100 (C+) ✓ STAGE-C NUMBER FIREWALL VERIFIED

IOSP — Innospec Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:25:31Z

1. Roarable Rating Brief: What This Means to a Prospective Investor

IOSP scores 70 out of 100 with a letter grade of B- and a verdict of "Roarable Buy — Sound Institutional Accumulation." The five pillars are: Fundamental Cash Engine at 14/20 (ROIC 9.9%; FCF yield 5.54%), Whale 13F Flow at 16/20 (institutional accumulation and options positioning), Insider Conviction at 13/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 13/20 (beta 1.0; sector sensitivity), and Forensic Balance Sheet at 14/20 (Altman Z 5.47; Piotroski F 4/9; Debt/Equity 0.5). The strongest pillar is institutional flow, while insider conviction and macro fit sit lower. For a prospective investor, the upside case rests on the cash-generation and balance-sheet pillars combined with accumulation signals. The valuation tradeoff is that the shares trade at an EV/EBITDA of 17 with a 5. The rating is a source-derived scoring output, not a recommendation to act.

2. Business Model, Unit Margins & SEC Financial Trajectory

Innospec Inc. Is a NASDAQ-listed issuer in the Materials sector, operating within the Major Chemicals industry, . The Snapshot and Financial Trend sections show reported revenue of $1.

Revenue declined across the three reported periods, and operating income fell from $177.9M in FY 2024 to $129.5M in FY 2025. Reported net income is — in each period and EPS is N/A. Per the market data, gross margin is 27.7%, operating margin 7.3%, and net margin 0%. ROIC is 9.9%. Per the RQD forensic pillar, Altman Z is 5.47, Piotroski F is 4/9, and Debt/Equity is 0.5. Cash was $292.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case: Per the RQD rating, institutional accumulation (16/20) and a 5.54% FCF yield support the cash-generation case. With Fundamental Cash Engine at 14/20 (ROIC 9.9%, FCF yield 5.54%) and Institutional Whale Flow at 16/20, sustained execution supports upside toward the top of the $65.51 – $102.00 52-week range.
🐻 Primary Bear Case: Reported revenue and operating income declined each year from FY 2023 to FY 2025, with net income at $0.0M. Investors must weigh current valuation and 17.0x EV/EBITDA against 7.3% operating margins and a 1.00 macro beta if sector demand softens.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

There are no upstream or downstream dependencies recorded (supply chain: NONE; butterfly links: none). No sector correlations or 2nd-order bottlenecks are specified in the source data. —

Key Question #1: What are IOSP's reported debt and EPS figures, which the financials leave as N/A or unreported, and how do they affect the forensic and valuation assessment?
Key Question #2: What drove the decline in revenue and operating income across FY 2023 through FY 2025?
Key Question #3: What is the basis for the 25% undervaluation claim referenced in the news wire, and what cash flow assumptions does it rely on?

IOSP Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Innospec Inc. (IOSP) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to IOSP Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 20h ago

Innospec Inc. (IOSP) Stock Forecasts

Yahoo Finance report covering Innospec Inc. (IOSP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 23h ago

Innospec Inc. Estimates – NASDAQ:IOSP

TradingView report covering Innospec Inc. (IOSP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Innospec (IOSP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Yahoo Finance report covering Innospec Inc. (IOSP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Simply Wall St • 1d ago

Innospec (IOSP) Stock Could Be 25% Undervalued Despite Steady Cash Flow

Simply Wall St report covering Innospec Inc. (IOSP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Benzinga • 1d ago

Innospec Q2 2026 Earnings Call: Complete Transcript

Benzinga report covering Innospec Inc. (IOSP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Traders Daily • 1d ago

How Innospec Inc. (IOSP) Affects Rotational Strategy Timing

Stock Traders Daily report covering Innospec Inc. (IOSP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Simply Wall St • 1d ago

Innospec (IOSP) Dropped, So What Is Drawing Attention Now?

Simply Wall St report covering Innospec Inc. (IOSP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo • 4d ago

Olin (OLN) Q3 Earnings Beat Estimates

Olin (OLN) delivered earnings and revenue surprises of +40.00% and -2.63%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

IOSP Bull vs. Bear Conversation Board — What's Your Call at $99.55?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON IOSP 🐻 33% BEARISH CONVICTION

TA TapeReader_Pro Price Action & Volume Trader 🐂 BULLISH 🎯 Target: $123.86 (+24.0%)

📌 Pinned Debate

Per the RQD rating, institutional accumulation (16/20) and a 5.54% FCF yield support the cash-generation case.

Here is why I am bullish on IOSP here at $99.89: Per the RQD rating, institutional accumulation (16/20) and a 5.54% FCF yield support the cash-generation case.. Compare IOSP's 7.3% operating margin and 9.9% ROIC against the rest of Major Chemicals. As long as cash conversion holds up, dips toward $94.90 are getting bought.

CapAlloc_Nerd 🐂 BULL

@TapeReader_Pro Agree on the RQD 69/100 quality, though with 1.0 beta I'm scaling in with half-size at $99.89 and keeping dry powder in case we test $92.90.

SK SkepticalCFA Fundamental Contrarian 🐻 BEARISH 🎯 Target: $75.92 (-24.0%)

Spot @ $99.89

Reported revenue and operating income declined each year from FY 2023 to FY 2025, with net income at $0.0M.

Sitting on the sidelines or leaning short IOSP above $99.89. Reported revenue and operating income declined each year from FY 2023 to FY 2025, with net income at $0.0M.. Until Fundamental Cash Engine (14/20) and FCF yield (5.54%) inflect higher, upside is capped near $102.00.